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Saudi ArabiaAbstract Background: Medication safety is a global concern among healthcare providers. How-
ever, the challenges to and the future of medication safety in Saudi Arabia have not been explored.
Objectives: We explored the perspectives of healthcare practitioners on current issues about
medication safety in hospitals and community settings in Saudi Arabia in order to identify chal-
lenges to improving it and explore the future of medication safety practice.
Methods: A total of 65 physicians, pharmacists, academics and nurses attended a one-day meet-
ing in March 2010, designed especially for the purpose of this study. The participants were divided
into nine round-table discussion sessions. Three major themes were explored in these sessions,
including: major factors contributing to medication safety problems, challenges to improving
medication safety practice, and participants’ suggestions for improving medication safety. The
round-table discussion sessions were videotaped and transcribed verbatim and analyzed by two
independent researchers.
Results: The round-table discussions revealed that major factors contributing to medication
safety problems included unrestricted public access to medications from various hospitals and com-
munity pharmacies, communication gaps between healthcare institutions, limited use of important
Challenges to and the future of medication safety in Saudi Arabia: A qualitative study 327technologies such as computerized provider order entry, and the lack of medication safety programs
in hospitals. Challenges to current medication safety practice identiﬁed by participants included
underreporting of medication errors and adverse drug reactions, multilingualism and differing
backgrounds of healthcare professionals, lack of communication between healthcare providers
and patients, and high workloads. Suggestions for improving medication safety practices in Saudi
Arabia included continuous education for healthcare professionals and competency assessment
focusing on medication safety, development of a culture that encourages medication error and
adverse drug reactions reporting, use of technology proven to decrease medication errors, and pro-
motion and implementation of national patient safety initiatives.
Conclusions: Healthcare professionals have identiﬁed major challenges and opportunities for
medication safety in Saudi Arabia. Policy makers and practitioners should consider these factors
when designing future programs aimed at improving the safe use of medications.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Medication errors are common and preventable adverse drug
events (ADEs) represent a major cause of harm. The incidence
of medication errors and ADEs has been studied in many epi-
demiologic studies, particularly in developed country contexts
(Bates et al., 1995; Gandhi et al., 2003; Morimoto et al., 2011;
Benkirane et al., 2009; Honigman et al., 2001; Leape et al.,
1995; Thomsen et al., 2007). For example, in the United States
(US), one study found that 6.5% of hospitalized adult patients
experienced ADEs, and 28% of these events were preventable
(Bates et al., 1995). A more recent study from Japan reported
an ADE incidence of 29 (95% CI; 27.7–30.7) per 100 admis-
sions and medication errors of 15 (95% CI; 13.7–16.0) per
100 admissions. In Morocco, ADEs were found to occur at a
rate of 11.5 (95% CI; 9.1–13.9) per 100 admissions (Benkirane
et al., 2009). In the US, it is estimated that medication errors
harm at least 1.5 million people, kill 106,000 people, and cost
at least $3.5 billion annually (Philip et al., 2006).
The overall incidence of ADEs in Saudi Arabia is un-
known. However, studies have reported a prescribing error
incidence of 8–56 per 100 medication orders in hospitalized pa-
tients (Al-Dhawailie, 2011; Al-Jeraisy et al., 2011). It has been
reported that 35% of medications dispensed without prescrip-
tion in Saudi Arabia are prescription only medications (Bawa-
zir, 1992). In addition, it was found that 37% of patients had a
medication discrepancy at the time of hospital admission
(AbuYassin et al., 2011), which could have been prevented
by accurate reconciliation of medications.
The current situation and healthcare practitioner’s perspec-
tives about medication safety practices in Saudi Arabia are un-
known. In this study, we adopted a qualitative approach to
explore the views and opinions of healthcare practitioners to-
ward current issues about medication safety in hospitals and
community settings in Saudi Arabia, to identify challenges to
improving it; and explore the future of medication safety
practice.
2. Methods
2.1. Study design
We conducted an exploratory qualitative enquiry using group
discussions for the generation of data. A topic guide was devel-
oped after conducting literature reviews of similar studies(Hartnell et al., 2006, 2012; Phipps et al., 2009). The topics in-
cluded in the guide for discussions were: current situation of
medication safety practice in Saudi Arabia, medication safety
issues, challenges and obstacles of medication safety and sug-
gestions to improve medication safety in the country (see
Appendix 1).
2.2. Sampling and recruitment
A list of experts in medication safety in Saudi Arabia was gen-
erated based on the authors’ recommendations and personal
contacts. Then, a personal email or phone invitation was sent
to those experts to participate in a one-day meeting in Riyadh,
Saudi Arabia. Participants came from government hospitals,
private hospitals, academia, pharmaceutical industries and
the Ministry of Health.
2.3. Data generation
Participants were divided into nine round-table discussion
groups. Because of the culture in Saudi Arabia, females and
males were seated in separate tables. Where possible, each
group included at least one pharmacist, a physician and a
nurse to facilitate discussion and the exchange of ideas be-
tween professionals from different backgrounds (Kitzinger,
1994). A facilitator was assigned in each group to facilitate
the discussion in the three main areas of interest. The partici-
pants’ ﬁlled a form to document their response to each ques-
tion. A summary of the group’s opinion in each theme was
generated. In a plenary discussion, each facilitator shared their
group summary with all participants by the help of a modera-
tor. Thereafter, the moderator gave the chance for any partic-
ipant to comment or add new points. During the discussion, if
the moderator felt that the participant’s statement was useful,
further questions were asked, for example, ‘‘would you elabo-
rate more on this?’’ The language of both, the plenary discus-
sion and the round-table discussion was English.
2.4. Data coding and analysis
The plenary discussion was videotaped, transcribed verbatim
and coded. Then, common themes were generated from the
transcript by two independent researchers, using thematic con-
tent analysis (Felicity, 2002). The ﬁnal coding and themes were
approved by four authors through consensus. Conﬁdentiality
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formed that no data that can lead to identiﬁcation of any par-
ticipant will be published in any form. Saturation was assessed
by reviewing the forms ﬁlled by each round-table discussion
group.
3. Results
3.1. Characteristics of participants
A total of 65 participants took part in the round-table discus-
sion: 14 hospital pharmacists, 12 clinical pharmacists, 9 medi-
cation safety ofﬁcers or hospital quality coordinators, 6
physicians, 5 pharmacy directors, 6 academics, 3 nurses, 3
health authorities, 3 community pharmacists, 2 representative
from the pharmaceutical industry, and 2 pharmacy students.
The majority of participants were females 41 (63%).
3.2. Main themes
We present below the main themes arising from the discussions
in each of the three broad areas of particular interest.
3.3. Factors contributing to medication safety problems
When discussing the problems, causes, and weaknesses of cur-
rent medication safety practice, participants pointed out many
factors such as the limited use of technology, unrestricted pub-
lic access to medicines from various hospitals and community
pharmacies, communication gaps between healthcare institu-
tions, and the lack of rigorous medication safety programs in
hospitals. Other factors mentioned included the lack of trained
staff in medication safety, such as medication safety ofﬁcers;
the unavailability or non-adherence to policies and procedures;
and the unavailability or non-adherence to guidelines ensuring
medication safety, such as the lack of proper labeling of med-
ications, lack of standardized look-alike and sound-alike lists
of drugs, and lack of implementation of medication
reconciliation.
3.3.1. Limited use of technology
Participants noted that a major contributor to prescribing er-
rors was physicians’ illegible handwriting. They suggested that
computerized provider order entry (CPOE) might alleviate the
problem. However, they recognized that a limited number of
hospitals had adopted CPOE, and believed that those hospitals
had not beneﬁted as much as might be expected from CPOE.
Pharmacy-information and bar-coding systems were also men-
tioned as important technologies that are lacking in most
healthcare institutions in Saudi Arabia.
‘‘One of the most important medication safety issues is of
course the design and compatibility of CPOE. If it is not
designed with functionality, taking into consideration effec-
tiveness, and with modalities to actually generate results
and reports to be able to work, otherwise you have a system
that looks nice but does not really work and help patient
safety’’ (Physician Round-table 1)
‘‘There is a lack of information-exchange database between
community pharmacies and hospital pharmacies in order toaccess patient information, diagnosis, medication history,
and laboratory results’’ (Pharmacist, Round-table 2)
‘‘Even if we have CPOE, as we have in our hospital. If it is
not fully integrated, we will have more mistakes, so we
should have an excellent system’’ (Pharmacist Round-table
4)3.3.2. Unrestricted access to medications from different hospitals
and community pharmacies across the country
Participants noted that medications are available to patients
from different sources because patients can have medical ﬁles
in several hospitals simultaneously. Also, regulations to elimi-
nate unauthorized access to medication in community pharma-
cies are not enforced, even though they exist.
‘‘For example, patients have ﬁles in different hospitals and
they can still go to community pharmacies and buy what-
ever medications they request without any restrictions,
and this will lead to a patient not having a clear and up-
to-date medications list that a physician can depend on
when the patient comes for a follow-up or admission’’ (Phy-
sician-Round-table 1)
‘‘All themedications in our community pharmacies are over–
the-counter, except narcotics, so you can dispense any medi-
cation for any patient’’ (Pharmacist- Round-table 4)3.3.3. Communication gaps between healthcare institutions
Participants believed that the communication between health-
care institutes has to be improved to avoid serious medication
errors.
‘‘A patient might get a prescription of controlled medica-
tion prescribed to him by the physician from one hospital
and then go to another hospital and get the same medica-
tion again prescribed to him so, obviously there will be
therapeutic duplication because of lack of uniﬁed commu-
nication tools between the hospitals’’ (Community Pharma-
cies Director, Round-Table 3)3.3.4. Absence of medication safety programs in hospitals
Most of the participants believed that underreporting of ad-
verse drug reactions (ADRs) and medication errors is caused
partially by insufﬁcient basic medication safety training for
healthcare providers and a lack of continuous education in
medication safety issues.
‘‘Each hospital has it is own characteristics, each has to
have its own medication safety program including commit-
tees, specialized medical staff, and medication error and
ADR reporting systems’’ (medication safety ofﬁcer, Round
table 8)3.4. Challenges to improving current medication safety practices
3.4.1. Underreporting of medication errors and ADRs
Participants believed that underreporting of medication errors
and ADRs is a considerable challenge to medication safety
programs. They also mentioned that the lack of knowledge
of medication errors and ADR reporting is a major barrier
to reporting ADEs.
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actually it’s worldwide, and one of the things that we dis-
covered was that, most of the time, healthcare professionals
do not know what to report and what exactly are the ADRs
that should be reported’’ (Member of Regulatory Body-
Round-Table 3)
‘‘Yes there is resistant from physician to report ADRs, but
what are you going to do? They are the primary frontline
users. You have to invest money to make the system easier
for them so that they don’t have to waste time’’ (Physician,
Round-table 1)3.4.2. Multilingualism and different backgrounds
Participants highlighted issues relating to the cultural diversity
and multilingualism among healthcare professionals who come
from different backgrounds and different healthcare systems.
Participants emphasized the impact on communication, espe-
cially with verbal orders.
‘‘When we talk about verbal orders, it is important to
consider the diverse multilingualism and multiculturalism
of healthcare professionals that we have in most of the
hospitals. We speak English with different dialects. So,
the need for read back, talk to me, explain to me, and
what you understood from me is very important to make
sure he or she knows what I mean’’ (Physician, Round-
table 1)3.4.3. Culture of safety
Some participants believed that fear of liability might be one of
the challenges to proper medication safety practice.
‘‘Most of the healthcare professionals will be reluctant to
report ADRs or medication errors because they don’t want
to get into trouble with the hospital administration’’ (Mem-
ber of Regulatory Body, Round-table 5)3.4.4. Communication between healthcare professionals
Participants believed that communication barriers between
healthcare professionals represent one of the most important
challenges to better medication safety practice.
‘‘The patient comes to me. I tell him one thing. He or she
goes to the nurse, and she tells him another thing, and
the pharmacist tells him something else. Then the patient
is confused, so, we need to have a standardized communi-
cation tool’’ (Physician, Round-table 5)3.4.5. Communication between healthcare professionals and
patients
Communication barriers between pharmacists and patients
were also identiﬁed as one of the challenges. Some of the par-
ticipants had an explanation for communication gaps between
pharmacists and patients.
‘‘There is no time for the community pharmacist to give
counseling to patients, and even if he wants to, there is no
private area for counseling’’ (Pharmacist, Round-table 4)
Social factors were another explanation for communication
gaps between community pharmacists and patients.‘‘Females are reluctant to communicate freely with the
pharmacist because all pharmacists in community
pharmacies are males’’ (Pharmacist, Round-table 4)3.4.6. Work load or inadequate number of staff
Participants identiﬁed workload as one of the challenges and
believed that it might contribute to medication errors.
‘‘In our hospital, the number of medications dispensed by
pharmacist is very huge; sometimes, it exceed 500 items
per pharmacist, and the possibility of committing dispens-
ing errors is high because of that’’ (Pharmacist, Round-
table 4)3.5. Suggestions for potential areas to improve medication safety
in Saudi Arabia
Participants were also requested to suggest improvements to
current medication safety practice in Saudi Arabia. Partici-
pants suggested taking steps to establish a safety culture, con-
tinuous education for the healthcare staff, and continuous
competency assessments that focus on medication safety. Fur-
ther, participants also suggested increasing the awareness of
healthcare professionals about the trend of medication errors
and the need for a uniﬁed database to ensure continuity of
care. They also raised the concern that there is not enough
published research in medication safety, especially about the
region, and articulated the need for rigorous research in med-
ication safety and the enrollment of medication safety ofﬁcers
in hospitals.3.5.1. Research
Most of the participants strongly endorsed the need for
more medication safety research to increase the understanding
of the type and causes of medication errors in Saudi
hospitals.
‘‘A well-structured and published research in medica-
tion safety is a key element for improvement, because I
know there are initiatives everywhere in different
hospitals, but there is no well-structured and pub-
lished research’’ (Hospital Pharmacy Director, Round-
table 7)3.5.2. Continuous education and competency assessment
Continuous education and continuous competency assess-
ments focusing on medication safety are needed to enhance
the current practice and help train healthcare professionals
about best practices in medication safety.
‘‘Continuous education and continuous compe-
tency assessment of our medical staff or healthcare
providers: we need to be sure that they are up to the
level of taking care of our patients’’ (Physician, Round-
table 1)
‘‘Nurses are involved in administration of medications to
patient and should be targeted and heavily involved in con-
tinuous education programs and competency assessment’’
(Nurse, Round-table 2)
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‘‘Even if they make an error, they keep it down so, in this
way, you can’t even evaluate which direction you are run-
ning and you cannot improve’’ (Hospital Pharmacy Direc-
tor, Round-table 4)3.5.4. Need for wider use of technology
Most of the participants believed that the correct use of tech-
nologies will improve medication safety.
‘‘Regarding prescribing errors, you can imagine that, some-
times, there is no dose, no dosage forms, and no frequency
written’’ (Pharmacist, Round-table 6)3.5.5. Need for national initiatives and support from the national
accreditation body
Participants agreed that efforts on the national level need to be
expanded to promote the implementation of medication safety
practices.
‘‘I think most hospital professionals are happy to learn they
are eager to know about proper medication safety practice,
so may be if we make the Saudi Central Board of Accred-
itation for Health Institutions (CBAHI) mandatory for all
Saudi hospitals I am sure it will improve medication safety
in our country’’ (medication safety ofﬁcer, Round-table 8)4. Discussion
We performed a qualitative study of provider beliefs and per-
spectives around medication safety in Saudi Arabia. Speciﬁc is-
sues identiﬁed included unrestricted public access to
medication from various sources, communication gaps, and
the lack of rigorous medication safety programs in hospitals
and the limited use of important technologies such as CPOE,
even though when it was implemented it did not always have
the desired effects.
Several studies have used qualitative approaches to under-
stand the perspective of either healthcare professionals and/
or patients toward various medication safety issues (Hartnell
et al., 2006, 2012; Phipps et al., 2009; Avery et al., 2007; Cres-
swell et al., 2012). In particular, medication errors and ADRs
have received attention in previous work. Similar to our ﬁnd-
ings, a recent study reported that the main barriers to medica-
tion error reporting include organizational factors, such as fear
of appraisal from management and/or administration; infor-
mation gaps, such as lack of deﬁnition or standards for report-
ing medication errors; and the inability to recognize or identify
medication errors (Phipps et al., 2009). Another recent study
from Malaysia reported that the lack of knowledge of ADRs
is a major factor contributing to underreporting (ElkalmiRM
et al., 2011).
The National Pharmacovigilance Centre at the Saudi Food
and Drug Authority (SFDA) made ADR reporting forms
available online for healthcare professionals and patients.
However, participants in this study were not satisﬁed with
the number of ADRs submitted on a national level. In addi-
tion, incident reporting in Saudi Arabian hospitals is less
widespread than reporting in other countries (Arabi et al.,
2012; Panesar et al., 2009).Pharmacists in the current study were concerned about the
heavy workload of pharmacists, and believed that it might
contribute to dispensing errors. Consistent with our ﬁndings,
a study from Australia reported that an increase in workload
created more opportunities for dispensing errors to occur in
community pharmacies (Peterson et al., 1999). Another study
from the US also found a positive correlation between the fre-
quency of dispensing errors and the number of prescriptions
(Szeinbach et al., 2007).
Communication is a fundamental aspect of clinical practice,
both among healthcare professionals and between healthcare
professionals and patients (Travaline et al., 2005; Kripalani
et al., 2007). In support of our ﬁndings, a recent national study
in Saudi Arabia reported that behavior and communication
incidents among hospital staff were one of the major incidents
reported through a voluntary incident reporting system (Arabi
et al., 2012). At the community pharmacy level, another na-
tional study reported that few patients mentioned that pharma-
cists discussed with or counseled them on personal matters in a
private area within the pharmacy (Bawazir, 2004). A systematic
review revealed that deﬁcits in communication and information
transfer at hospital discharge are common and identiﬁed several
interventions to facilitate patient-information transfer during
continuity of care (Travaline et al., 2005). In Saudi Arabia, it
was found that 37% of patients had a medication discrepancy
at admission (AbuYassin et al., 2011), which could have been
prevented by accurate reconciliation of medications.
International studies support the idea that medication er-
rors can occur any time during the medication-management
process and most commonly during prescribing (Bates et al.,
1995; Avery et al., 2002). Similarly, in Saudi Arabia, clinicians
are concerned about prescribing errors, and few studies have
been conducted in both hospitals and primary care settings
(Al-Dhawailie, 2011; Al-Jeraisy et al., 2011; Neyaz et al.,
2011a,b; Al-Faris, 1999; Mahfouz et al., 1997). Study partici-
pants were also very concerned about prescribing errors be-
cause of illegible handwriting. Similarly, a local study
reported that 72% of the physicians in Saudi Arabia write
low-quality prescriptions (Neyaz et al., 2011b). As a way to re-
duce or eliminate these errors, participants suggested the use of
CPOE. It has been documented that CPOE has a positive im-
pact on medication errors when implemented correctly (Bates
et al., 1999). Nevertheless, recent studies reported that, com-
puter system may also in some instances cause medication er-
rors (Koppel et al., 2005; Kesselheim et al., 2011).
Our study had several limitations. Some participants might
not have contributed to the discussion because of the large size
of the plenary discussions. Most participants were pharma-
cists, and nurses or hospital administrators were included
but relatively underrepresented especially nurses. In addition
the inclusion of patients or their caregivers was not considered.
Also the discussion was only one day and hence one-to-one
discussion was not possible. Our result might not be generaliz-
able beyond the Saudi context.
Future initiatives should consider the issues raised in this
study in designing programs aimed at improving the safe use
of medication. The study ﬁndings also highlighted the need
for the implementation of interventional, research and educa-
tional services to ensure the safe use of medications.
These group discussions of healthcare professionals have
identiﬁed major challenges and opportunities for medication
safety in Saudi Arabia. Policy makers and practitioners may
Challenges to and the future of medication safety in Saudi Arabia: A qualitative study 331consider these factors when designing future programs aimed
at improving the safe use of medication.
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 In your opinion, what are the important medication-safety
problems encountered in the hospitals and the community
setting?
 Prioritize these problems.
 What do you think causes these problems?
 How Saudi Arabia is unique compared to other western
countries in this area?
 What are the strengths we have in medication safety in
Saudi Arabia: these include resources, research, practice,
and regulations?
 What are the weaknesses we have in medication safety in
Saudi Arabia: these include resources, research, practice
and regulations?
 What are the challenges that we should prepare for?
 What are the opportunities in improving medication safety
in Saudi Arabia?
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